Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: A conflict of paradigms revisited

Schizophrenia Research

Volumn 40, Issue 3, 1999, Pages 245-253

  Peralta, Victor ^a   Cuesta, Manuel J ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Catatonic symptoms; Depressive symptoms; Extrapyramidal symptoms; Negative symptoms; Neuroleptic treatment; Schizophrenia

Indexed keywords

BIPERIDEN; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CATATONIA; CLINICAL ARTICLE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MENTAL DISEASE; PARKINSONISM; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AFFECTIVE SYMPTOMS; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIA, CATATONIC;

EID: 0032697694     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00047-X     Document Type: Article

References (36)

1. Addington D., Addington J., Maticka-Tyndale E. Reliability and validity of a depression rating scale for schizophrenia. Schizophr. Res. 6:1992;201-208.
2. Addington D., Addington J., Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics. Schizophr. Res. 11:1994;239-244.
3. Addington D., Addington J., Atkinson M. A psychometric comparison of the Calgary scale for depression and the Hamilton depression scale. Schizophr. Res. 19:1996;205-212.
4. Andreasen N.C., Olsen S. Positive vs. negative schizophrenia: definition and validation. Arch. Gen. Psychiatry. 39:1982;789-794.
5. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS). 1984;University of Iowa, Iowa City.
6. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SANS). 1984;University of Iowa, Iowa City
7. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC.
8. Barnes T.R.E., Curson D.A., Liddle P.F., Patel M. The nature and prevalence of depression in chronic schizophrenic in-patients. Br. J. Psychiatry. 154:1989;486-491.
9. Barnes T.R.E., McPhillips M.A. How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia. Int. J. Psychpharmacol. 10:1995;115-121.
10. Bermanzohn P.C., Siris S.G. Akinesia: a syndrome common to parkinsonism, retarded depression and negative symptoms of schizophrenia. Compr. Psychiatry. 33:1992;221-232.
11. Bishop M.P., Gallant D.M., Sykes T.F. Extrapyramidal side effects and therapeutic response. Arch.Gen. Psychiatry. 13:1965;155-162.
12. Bush G., Petrides G., Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr. Res. 27:1997;83-92.
13. Caligiuri M.P., Lohr J.B., Jeste P.V. Parkinsonism in neuroleptic-naive schizophrenic patients. Am. J. Psychiatry. 150:1993;1343-1348.
14. Carpenter W.T., Heinrichs D.W., Wagman A.M.I. Deficit and nondeficit forms of schizophrenia. The concept. Am. J. Psychiatry. 145:1988;578-583.
15. Chatterjee A., Chakos M., Koreen A., Geisler A., Sheitman B., Woermer M., Kane J.K., Alvir J., Lieberman J.A. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am. J. Psychiatry. 152:1995;1724-1729.
16. Collins A.A., Remington G., Coulter K., Birkett K. Depression in schizophrenia: a comparison of three measures. Schizophr. Res. 20:1996;205-209.
17. Gelenberg A.J., Mandel M.R. Catatonic reactions to high-potency neuroleptics drugs. Arch. Gen. Psychiatry. 34:1977;947-950.
18. Harrow M., Yonan C.A., Sands J.R., Marengo J. Depression in schizophrenia: are neuroleptics, akinesia or anhedonia involved? Schizophr. Bull. 20:1994;327-338.
19. Kane J.M., Safferman A.Z., Pollack S., Johns C., Szymanski S., Kronig M., Lieberman J.A. Clozapine, negative symptoms and extrapyramidal side effects. J. Clin. Psychiatry. 55:(Suppl. B):1994;74-77.
20. Kopala L.C., Good K.P., Fredrikson D., Whitehorn D., Lazier L., Honer W.G. Risperidone in first-episode schizophrenia: improvement in symptoms and pre-existing extrapyramidal signs. Int. J. Psychiatr. Clin. Pract. 2:1998;19-25.
21. Koreen A.R., Siris S.G., Chakos M., Alvir J., Mayerhoff D., Lieberman J. Depression in first-episode schizophrenia. Am. J. Psychiatry. 150:1993;1643-1648.
22. Liddle P.F. The psychomotor disorders: disorders of the supervisory mental processes. Behav. Neurol. 6:1993;5-14.
23. Lund C.E., Mortimer A.M., Rogers D., McKenna P.J. Motor, volitional and behavioural disorders in schizophrenia.1: assessment using the modified Rogers scale. Br. J. Psychiatry. 158:1991;323-327.
24. McCreadie R.G., Robertson L.J., Wiles D. The Nithsdale schizophrenia surveys, IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic leels. Br. J. Psychiatry. 161:1992;793-799.
25. McKenna P.J., Lund C.E., Mortimer A.M., Biggins C.A. Motor, volitional and behavioural disorders in schizophrenia. 2: The conflict of paradigms' hypothesis. Br. J. Psychiatry. 158:1991;328-336.
26. Nakaya M., Ohmori K., Komahashi T., Suwa H. Depressive symptoms in acute schizophrenic patients. Schizophr. Res. 25:1997;131-139.
27. Peralta V., Cuesta M.J., Farre C. Factor structure of symptoms in functional psychoses. Biol. Psychiatry. 42:1997;806-815.
28. Perenyi A., Norman T., Hopwood M., Burrows G. Negative symptoms, depression and parkinsonian symptoms in chronic, hospitalized schizophrenic patients. J. Aff. Dis. 48:1998;163-169.
29. Prosser E.S., Csernansky J.G., Kaplan J., Thieman S., Becker T.J., Hollister L.E. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. J. Nerv. Ment. Dis. 175:1987;100-105.
30. Rifkin A., Quitkin F., Klein D.F. Akinesia: a poorly recognized drug-induced extrapyramidal disorder. Arch. Gen. Psychiatry. 32:1975;672-675.
31. Salokangas R.K.R. Structure of schizophrenic symptomatology and its change over time: prospective factor-analytic study. Acta Psychiatr. Scand. 95:1997;32-39.
32. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. 10:1970;199-208.
33. Siris S.G., Strahan A., Mandeli J., Cooper T.B., Casey E. Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression. Schizophr. Res. 1:1988;31-35.
34. Starkstein S.E., Petracca G., Tesón A., Chereminski E., Merello M., Migliorelly R., Leiguarda R. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J. Neurol. Neurosurg. Psychiatry. 60:1996;326-332.
35. Tugg L.A., Desai D., Prendergast P., Remington G., Reed K., Zipursky R.B. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects. Schizophr. Res. 25:1997;71-78.
36. Van Putten T., May P.R. 'Akinetic depression' in schizophrenia. Arch. Gen. Psychiatry. 35:1978;1101-1107.